Wednesday, June 27, 2012

Arena wins approval

The FDA, as I expected, approve Arena's drug today, following last month's 18-4 Advisory Committee positive vote. The drug will sell under the name Belviq and is for weight loss - the first such drug approved in the last 13 years. The full release can be viewed here: http://finance.yahoo.com/news/arena-pharmaceuticals-eisai-announce-fda-171300471.html Congratulations to any who were long here. I believe the fun is just getting started. Best regards, Trond Hildahl

No comments: